Table 2.
Incidence of In-Hospital Outcomes
| Outcome | DD ≤ 0.69(n = 306) | DD > 0.69 (n = 244) |
P-value | CI-AKI(−) (n = 478) |
CI-AKI(+) (n = 72) |
P-value |
|---|---|---|---|---|---|---|
| CI-AKI | 16 (5.2%) | 56 (23.0%) | < 0.0001 | |||
| In-hospital mortality, n (%) | 3 (1.0%) | 18 (7.4%) | < 0.0001 | 9 (1.9%) | 12 (16.7%) | < 0.0001 |
| Recurrent MI, n (%) | 1 (0.3%) | 4 (1.6%) | 0.176 | 4 (0.8%) | 1 (1.4%) | 0.506 |
| Required RRT, n (%) | 1 (0.3%) | 7 (2.9%) | 0.025 | 4 (0.8%) | 4 (5.6%) | 0.013 |
| Stent thrombosis, n (%) | 1 (0.3%) | 1 (0.4%) | 1.000 | 1 (0.2%) | 1 (1.4%) | 0.245 |
| Bleeding, n (%) | 4 (1.3%) | 4 (1.6%) | 0.738 | 4 (0.8%) | 4 (5.6%) | 0.013 |
| Hospitalization length, days | 12.52 ± 6.49 | 13.72 ± 7.68 | 0.081 | 12.75 ± 6.42 | 15.21 ± 10.30 | 0.015 |
| Hospital costs, RMB | 66,165.01 ± 28,815.73 | 76,070.04 ± 43,063.55 | 0.005 | 67,989.403 ± 1357.43 | 88,876.34 ± 56,971.9 | < 0.0001 |
| 6-months mortality | 3 (1.0%) | 22 (9.0%) | < 0.0001 | 13 (2.7%) | 12 (16.7%) | < 0.0001 |
| 12-months mortality | 5 (1.6%) | 24 (9.8%) | < 0.0001 | 17 (3.6%) | 12 (16.7%) | < 0.0001 |
Abbreviations: CI-AKI contrast-induced acute kidney injury, DD D-Dimer, RRT renal replacement therapy, MI mycardial infarction, RMB renminbi